How Your Brand Can Capitalize on the International Ecommerce Explosion

Designed for retail leaders and lovers alike, Retail Refined explores the in-store technology of the future, challenges the industry’s preconceived notions, and brings together retail’s biggest names to understand the brand strategies that will define the next decade in retail.

 

Last year saw a 35% increase in cross-border e-commerce as a result of the pandemic keeping consumers at home. While brands have unprecedented access to growth outside their home markets, many don’t have the digital capabilities and local expertise they need to fully leverage international opportunities.

Will this massive expansion of global e-commerce continue unabated? To discuss current trends in cross-border e-commerce and whether these changes in consumer behavior are sticky, host Melissa Gonzales welcomed Patrick Bousquet-Chavanne the President and CEO, Americas at eShopWorld, the world’s leading cross-border e-commerce solution provider.

“This is one of the most important opportunities today for brands, whether they are small to medium-sized enterprises or whether they are large-sized enterprises, to start capturing global potential and start to be relevant to a global customer base.” – Patrick Bousquet-Chavanne

Localization of e-commerce solutions is essential to international brand expansion. Gonzalez and Bousquet-Chavanne delved into the need for native currency pricing as well as local, secure payment options, easy returns, and trackable shipping. Reducing friction in these creates a personalized experience that fosters loyalty with consumers looking for convenience and ease of discovery. “The world is discovering that regardless of where you’re located you now have access to the global catalog of the world’s best brands.” Bousquet-Chavanne said. He points out that by the end of 2021, 70% of consumers will have made a cross-border purchase.

Will these trends continue? How do brands take advantage of this explosion in international e-commerce? What are the best strategies? Gonzalez and Bousquet-Chavanne have insights into this fast growing sector of retail and how it will shape brands in the future.

Listen to Previous Episodes of Retail Refined Right Here!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More